GlassScriptPhysician profile
Ashley Jean Jensen
NPI 1396357307
$1,239.23
in general payments reported to CMS, 2019-2025
19 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $254 · 2023: $387 · 2024: $292 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $227.52 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $150.29 | 2021-2023 | Verquvo |
| Boston Scientific Corporation | $128.17 | 2023-2024 | Watchman Flx, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $108.49 | 2025 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $105.59 | 2024-2025 | Inspire |
| Indivior INC. | $94.27 | 2023-2024 | Sublocade |
| Novo Nordisk INC | $73.85 | 2021-2023 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.79 | 2021-2024 | Jardiance |
| Lilly USA, LLC | $65.37 | 2021-2024 | Jardiance, Mounjaro |
| Alkermes, INC. | $51.51 | 2022 | |
| Organon LLC | $27.07 | 2022-2023 | Nexplanon |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.08 | 2022 | |
| Seqirus USA INC | $20.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.23 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.71 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.14 | 2022 | |
| Pfizer INC. | $14.84 | 2024 | |
| Idorsia Pharmaceuticals US INC | $14.79 | 2023 | Quviviq |
| Medtronic, INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.